Prab: CSV import

2025-02-13T03:36:50Z

CSV import

← Older revision		Revision as of 03:36, 13 February 2025
Line 1:		Line 1:
	~~'''~~PHCCC''' is a selective, non-competitive [[antagonist]] at the [[metabotropic glutamate receptor]] subtype [[mGluR4]]. It has been used in scientific research to explore the role of mGluR4 in the [[central nervous system]].		== PHCCC ==

	~~==Pharmacology==~~		[[File:PHCCC_structure.png\|thumb\|right\|Chemical structure of PHCCC]]
	~~PHCCC acts as a positive~~ [[~~allosteric modulator]] at mGluR4~~. ~~This means it binds to a site on the receptor different from the [[glutamate]] binding site, and enhances the receptor's response to its natural [[ligand~~]]~~, glutamate. The exact binding site of PHCCC on mGluR4 is not known, but it is thought to be within the seven-transmembrane domain of the receptor.~~

	~~==Uses in Research==~~		'''PHCCC''' is a chemical compound that acts as a positive allosteric modulator of the [[metabotropic glutamate receptor]] subtype 4 (mGluR4). It is of interest in the field of [[neuroscience]] and [[pharmacology]] for its potential therapeutic effects in various neurological disorders.
	PHCCC ~~has been used in research to investigate~~ the ~~role of~~ mGluR4 ~~in various neurological and psychiatric disorders~~. ~~For example, it has been used~~ in ~~studies~~ of [[~~Parkinson's disease]], [[schizophrenia~~]], and [[~~anxiety disorders~~]]~~. These studies have suggested that mGluR4 may be a~~ potential therapeutic ~~target for these conditions~~.

	==~~Chemistry~~==		=== Chemical Properties ===
	PHCCC is a synthetic compound. Its chemical ~~name~~ is ~~(RS)-N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide~~. ~~It is usually supplied as a white to off-white powder~~.		PHCCC is a synthetic compound with a specific chemical structure that allows it to interact with mGluR4. The structure of PHCCC is shown in the image to the right. Its chemical formula is C<sub>18</sub>H<sub>14</sub>ClNO<sub>2</sub>, and it has a molecular weight of 311.76 g/mol.

	==~~Safety~~==		=== Mechanism of Action ===
	~~As with all research chemicals~~, PHCCC ~~should be handled with care. It is not intended for human consumption~~.		PHCCC functions as a positive allosteric modulator, meaning it binds to a site on the mGluR4 receptor that is distinct from the active site. This binding enhances the receptor's response to its natural ligand, [[glutamate]]. By modulating mGluR4 activity, PHCCC can influence [[synaptic transmission]] and [[neurotransmitter]] release in the [[central nervous system]].

	==~~See Also~~==		=== Potential Therapeutic Applications ===
			Research into PHCCC has suggested potential applications in treating [[neurological disorders]] such as [[Parkinson's disease]], [[anxiety]], and [[schizophrenia]]. By modulating mGluR4, PHCCC may help to restore balance in neurotransmitter systems that are disrupted in these conditions.

			=== Research and Development ===
			Studies on PHCCC have primarily been conducted in [[preclinical]] settings, using [[animal models]] to assess its efficacy and safety. These studies have shown promising results, but further research is needed to determine its potential as a therapeutic agent in humans.

			== Related Pages ==
	* [[Metabotropic glutamate receptor]]		* [[Metabotropic glutamate receptor]]
	* [[Allosteric modulator]]		* [[Allosteric modulator]]
	* [[~~Glutamate~~]]		* [[Neurotransmitter]]
			* [[Parkinson's disease]]

	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	[[Category:Neuroscience]]		[[Category:Neuroscience]]
	~~[[Category:Research chemicals]]~~
	~~{{pharmacology-stub}}~~
	~~{{neuroscience-stub}}~~
	~~{{chem-stub}}~~

Prab: CSV import

2024-03-06T20:21:39Z

CSV import

New page

'''PHCCC''' is a selective, non-competitive [[antagonist]] at the [[metabotropic glutamate receptor]] subtype [[mGluR4]]. It has been used in scientific research to explore the role of mGluR4 in the [[central nervous system]].

==Pharmacology==
PHCCC acts as a positive [[allosteric modulator]] at mGluR4. This means it binds to a site on the receptor different from the [[glutamate]] binding site, and enhances the receptor's response to its natural [[ligand]], glutamate. The exact binding site of PHCCC on mGluR4 is not known, but it is thought to be within the seven-transmembrane domain of the receptor.

==Uses in Research==
PHCCC has been used in research to investigate the role of mGluR4 in various neurological and psychiatric disorders. For example, it has been used in studies of [[Parkinson's disease]], [[schizophrenia]], and [[anxiety disorders]]. These studies have suggested that mGluR4 may be a potential therapeutic target for these conditions.

==Chemistry==
PHCCC is a synthetic compound. Its chemical name is (RS)-N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide. It is usually supplied as a white to off-white powder.

==Safety==
As with all research chemicals, PHCCC should be handled with care. It is not intended for human consumption.

==See Also==
* [[Metabotropic glutamate receptor]]
* [[Allosteric modulator]]
* [[Glutamate]]

[[Category:Pharmacology]]
[[Category:Neuroscience]]
[[Category:Research chemicals]]
{{pharmacology-stub}}
{{neuroscience-stub}}
{{chem-stub}}

PHCCC - Revision history

Prab: CSV import

Prab: CSV import